UNICREDIT BANK/CALL/ELI LILLY & CO/750/0.1/18.06.25 | Real-time BOERSE MUENCHEN 20:42:15 25/06/2024 BST | ||
| 20.6 EUR | +3.31% |
|
| Current month | +39.47% | ||
| 1 month | +41.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 20.6 | +3.31% |
| 24/06/24 | 19.94 | +1.94% |
| 21/06/24 | 19.56 | +1.66% |
| 20/06/24 | 19.24 | -2.34% |
| 19/06/24 | 19.7 | 0.00% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 08:42 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC82T8 |
| ISIN | DE000HC82T82 |
| Date issued | 17/07/2023 |
| Strike | 750 $ |
| Maturity | 18/06/2025 (358 Days) |
| Parity | 10 : 1 |
| Emission price | 1.38 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 20.86 € |
|---|---|
| Lowest since issue | 0.9 € |
| Delta | 0.81x |
| Omega | 3.304 |
| Premium | 7.5x |
| Gearing | 4.07x |
| Moneyness | 1.206 |
| Difference Strike | -154.6 $ |
| Difference Strike % | -20.61% |
| Spread | 0.41 € |
| Spread % | 1.96% |
| Theoretical value | 20.77 |
| Implied Volatility | 31.99 % |
| Total Loss Probability | 27.86 % |
| Intrinsic value | 14.43 |
| Present value | 6.333 |
| Break even | 972.46 € |
| Theta | -0.11x |
| Vega | 0.22x |
| Rho | 0.47x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
904.6
USD
Average target price
860.5
USD
Spread / Average Target
-4.87%
- Stock Market
- Warrants
- Warrant
